Discontinued — last reported Q2 '25
Equity
Redeemable NCI
Amphenol Redeemable NCI increased by 1.0% to $10.20M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 50.7%, from $20.70M to $10.20M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2023
Last reportedQ2 2025
How to read this metric
An increase indicates a potential future cash outflow obligation, which could impact liquidity.
Detailed definition
This represents equity interests in subsidiaries held by third parties that have redemption features, allowing the holde...
Peer comparison
Common in companies with complex joint ventures or partially owned subsidiaries.
Metric ID:
redeemable_noncontrolling_interestsHistorical Data
16 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.00M | $19.50M | $19.90M | $20.20M | $20.60M | $20.90M | $21.40M | $21.80M | $30.70M | $30.90M | $19.90M | $20.70M | $8.70M | $9.30M | $10.10M | $10.20M |
| QoQ Change | — | +2.6% | +2.1% | +1.5% | +2.0% | +1.5% | +2.4% | +1.9% | +40.8% | +0.7% | -35.6% | +4.0% | -58.0% | +6.9% | +8.6% | +1.0% |
| YoY Change | — | — | — | — | +8.4% | +7.2% | +7.5% | +7.9% | +49.0% | +47.8% | -7.0% | -5.0% | -71.7% | -69.9% | -49.2% | -50.7% |
Range$8.70M – $30.90M
CAGR-15.3%
Avg YoY Growth-10.5%
Median YoY Growth+1.1%
Current Streak3 quarters growth
Redeemable NCI at Other Companies
Frequently Asked Questions
- What is Amphenol's redeemable nci?
- Amphenol (APH) reported redeemable nci of $10.20M in Q3 2025.
- How has Amphenol's redeemable nci changed year-over-year?
- Amphenol's redeemable nci decreased by 50.7% year-over-year, from $20.70M to $10.20M.
- What does redeemable nci mean?
- Equity held by others in a subsidiary that the company may be required to repurchase.